East Asia's Cell & Gene Therapy Landscape: Latest Advancements and Pipelines

Cell and Gene Therapy (CGT) is transforming the treatment landscape for cancer, rare diseases, and degenerative conditions. East Asia comprising of China, Japan, South Korea, and Taiwan has emerged as a global innovation hub, driven by:

Supportive regulatory frameworks
World-class clinical research
Growing Manufacturing capacity
Strong public–private investments

Complete the Form to get Full Access the Webinar Video

First Name

Last Name

Professional E-mail

Job Title

Company Name

Phone Number

Country

You acknowledge and agree to IMAPAC's Term of Service and to use your contact information provided to communicate with about offerings by IMAPAC, its brands, affiliates and/or third-party partners consistent with IMAPAC's Privacy Policy.

Thank you! Click below to view/download:

Oops! Something went wrong while submitting the form.